Dropropizine
Chemical compound
- R05DB19 (WHO)
- (RS)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol
- 17692-31-8
- 3169
- 3057
Y
- U0K8WHL37U
- D07393 Y
- ChEMBL151445 Y
- DTXSID0045624
- Interactive image
- OC(CN2CCN(c1ccccc1)CC2)CO
InChI
- InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2Y
- Key:PTVWPYVOOKLBCG-UHFFFAOYSA-NY
Dropropizine (or dipropizine) is a cough suppressant[1] that is sold in Germany, Central America, South America, and some African countries such as Congo. It is sold as suppositories, tablets, and syrup. It is used to stop a cough caused by allergies or a cold.[2]
Side effects
Adverse effects include drowsiness, nausea, heartburn, and respiratory depression.[2]
See also
- Levodropropizine
References
- ^ De Blasio F, Dicpinigaitis PV, Rubin BK, De Danieli G, Lanata L, Zanasi A (January 2012). "An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome". Cough. 8 (1): 1. doi:10.1186/1745-9974-8-1. PMC 3274450. PMID 22269875.
- ^ a b Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 71. ISBN 0-8103-7177-4.
- v
- t
- e
Cough and cold preparations (R05)
- Acetylcysteine#
- Ambroxol
- Bromhexine
- Carbocisteine
- Dembrexine hydrochloride
- Domiodol
- Dornase alfa
- Eprazinone
- Erdosteine
- Letosteine
- Mannitol
- Mesna
- Neltenexine
- Sobrerol
- Stepronin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
